QQ客服 官方微博 反馈留言

	Progress of CDK4/6 Inhibitor Palbociclib in the Treatment of Cancer
	Chen, Fengquan; Liu, Chunxi; Zhang, Jian; Xu, Wenfang; Zhang, Yingjie
刊名	ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
	2018
卷号	18期号:9页码:1241-1251
关键词	Cyclin-Dependent Kinases (CDKs) palbociclib monotherapy combined therapy anti-cancer cell cycle arrest
DOI	10.2174/1871521409666170412123500
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4579082
专题	山东大学
作者单位	Shandong Univ, Dept Med Chem, Sch Pharmaceut Sci, 44 West Culture Rd, Jinan 250012, Shandong, Peoples R
推荐引用方式 GB/T 7714	Chen, Fengquan,Liu, Chunxi,Zhang, Jian,et al. Progress of CDK4/6 Inhibitor Palbociclib in the Treatment of Cancer[J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY,2018,18(9):1241-1251.
APA	Chen, Fengquan,Liu, Chunxi,Zhang, Jian,Xu, Wenfang,&Zhang, Yingjie.(2018).Progress of CDK4/6 Inhibitor Palbociclib in the Treatment of Cancer.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY,18(9),1241-1251.
MLA	Chen, Fengquan,et al."Progress of CDK4/6 Inhibitor Palbociclib in the Treatment of Cancer".ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY 18.9(2018):1241-1251.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。